Laparoscopic cytoreductive surgery and HIPEC for colorectal and appendiceal peritoneal metastases: a propensity score-matched comparative study
This propensity score-matched study demonstrates that laparoscopic cytoreductive surgery with HIPEC is a safe and feasible alternative to open surgery for selected patients with colorectal and appendiceal peritoneal metastases, offering reduced operative time, blood loss, hospital stay, and overall morbidity while maintaining comparable major complication rates and short-term survival outcomes.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When cancer spreads from the colon or appendix to the lining of the abdomen, it creates a complex and difficult situation known as peritoneal metastases. This pattern of spread is distinct from cancer moving to distant organs like the liver or lungs; instead, it coats the inner surface of the belly, often causing severe complications and limiting survival. For carefully selected patients, a specialized treatment has emerged that combines two steps: a surgery to physically remove all visible tumors, followed by a bath of heated chemotherapy delivered directly inside the abdomen to kill any remaining microscopic cells. This combined approach, known as cytoreductive surgery with heated intraperitoneal chemotherapy, has long been the standard, but it traditionally requires a large incision down the center of the abdomen, similar to opening a door to access the room inside. Such a large opening causes significant trauma to the body, leading to longer recovery times and higher risks of complications. As surgical skills have advanced, doctors began asking whether this life-saving treatment could be performed using tiny keyhole incisions and a camera, a method called laparoscopy, which is less invasive and might help patients recover faster without sacrificing the effectiveness of the cancer treatment.
Researchers at the Hospital Clínic de Barcelona set out to answer this question by comparing the traditional open surgery with the newer laparoscopic approach. They focused on patients with colorectal or appendiceal cancer that had spread to the abdominal lining. To ensure a fair comparison, the team used a statistical method to pair nineteen patients who received the laparoscopic procedure with thirty-eight patients who underwent the traditional open surgery. They matched these groups based on age, sex, overall health, the extent of the cancer spread, and the location of the original tumor, effectively creating two groups that were nearly identical in their starting conditions. The study looked at how the surgeries went, how long patients stayed in the hospital, and what happened to them afterward.
The results showed that the laparoscopic approach offered clear advantages in the immediate aftermath of the operation. Patients who underwent the keyhole surgery spent significantly less time on the operating table, with procedures lasting a median of 240 minutes compared to 312 minutes for the open group. They also lost less blood during the surgery, with a median loss of 100 milliliters versus 300 milliliters for those with the large incision. Perhaps most notably for the patients' quality of life, the laparoscopic group left the hospital much sooner, with a median stay of just four days compared to eight days for the open surgery group. The study found that overall complications were much less common in the laparoscopic group, occurring in about 26 percent of patients, compared to more than 60 percent in the open group. However, when looking at the most serious complications, the rates were nearly identical between the two groups, suggesting that the less invasive method did not increase the risk of severe problems.
In terms of the cancer itself, the study found that the laparoscopic method was just as effective at removing the disease as the open method. All patients in both groups achieved complete removal of visible tumors. At the time of the last follow-up, the patients who had the laparoscopic surgery were more likely to be alive and free of disease, though the difference in overall survival rates between the two groups was not statistically significant, meaning the data did not definitively prove one method was better for long-term survival than the other. The researchers noted that the laparoscopic group had a slightly shorter follow-up period, which makes long-term conclusions difficult to draw with absolute certainty.
The study concludes that for carefully selected patients with a lower burden of cancer spread, the laparoscopic approach is a safe and feasible alternative to traditional open surgery. It allows surgeons to perform the same complex cancer removal with less trauma to the body, resulting in faster recovery and fewer overall complications, while maintaining the same high standards for removing the cancer and preventing severe adverse events. The authors emphasize that this success relies on the surgeons having extensive experience in advanced laparoscopic techniques. While the short-term results are promising, the researchers state that larger, prospective studies are needed to confirm these findings and to determine if the laparoscopic approach offers any long-term survival benefits over the traditional method.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.